Clinical Trials in North Carolina

Showing 1261-1280 of 20,428 trials

SNIFF Multi-Device Study 2

NCT04199767

The SNIFF Device study will involve using one of three devices to administer insulin through each participant's nose or intra-nasally, accompanied by a lumbar puncture. This goal of this study is to measure how much insulin the device delivers to the cerebrospinal fluid (CSF). In addition, this study will look at the effects of insulin administered intra-nasally on memory, and on blood levels of insulin.

Mild Cognitive ImpairmentCognitive Impairment

Wake Forest University Health Sciences13 participantsStarted Jul 2020

Winston-Salem, North Carolina, United States

Active Not RecruitingNA41 miles

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

NCT06911632

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

Pulmonary HypertensionInterstitial Lung Disease (ILD)

Tempus AI1,000 participantsStarted Jul 2025

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +22 more locations

SNIFF Multi-Device Study 2

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Find Trials by Condition in North Carolina

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The Lilac Device Trial

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis